相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evaluation of potential of miR-8073 and miR-642 as diagnostic markers in pancreatic cancer
Mohadeseh Fathi et al.
MOLECULAR BIOLOGY REPORTS (2022)
Circulating microRNAs: Challenges with their use as liquid biopsy biomarkers
Satoko Takizawa et al.
CANCER BIOMARKERS (2022)
Host genetics impact on SARS-CoV-2 vaccine-induced immunoglobulin levels and dynamics: The role of TP53, ABO, APOE, ACE2, HLA-A, and CRP genes
Donato Gemmati et al.
FRONTIERS IN GENETICS (2022)
Evaluation of Serum microRNA Let-7c and Let-7d as Predictive Biomarkers for Metastatic Pancreatic Cancer
Atike Gokcen Demiray et al.
TURKISH JOURNAL OF GASTROENTEROLOGY (2022)
MicroRNA-593-3p Expression in Peritoneal Lavage Fluid as a Prognostic Marker for Pancreatic Cancer Patients Undergoing Staging Laparoscopy
Tatsuo Hata et al.
ANNALS OF SURGICAL ONCOLOGY (2021)
Circulating miR-21 as a potential biomarker in human digestive system carcinoma: a systematic review and diagnostic meta-analysis
Amir Hossein Aalami et al.
BIOMARKERS (2021)
The role of microRNA-21 in the onset and progression of cancer
Ashutosh Singh et al.
FUTURE MEDICINAL CHEMISTRY (2021)
Serum miR-373-3p and miR-194-5p Are Associated with Early Tumor Progression during FOLFIRINOX Treatment in Pancreatic Cancer Patients: A Prospective Multicenter Study
Fleur van der Sijde et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Panel of serum miRNAs as potential non-invasive biomarkers for pancreatic ductal adenocarcinoma
Imteyaz Ahmad Khan et al.
SCIENTIFIC REPORTS (2021)
Plasma miRNA Biomarkers in Limited Volume Samples for Detection of Early-stage Pancreatic Cancer
Rachel L. Dittmar et al.
CANCER PREVENTION RESEARCH (2021)
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Matthew J. Page et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Circulating MiR-1290 as a potential diagnostic and disease monitoring biomarker of human gastrointestinal tumors
Liyi Xu et al.
BMC CANCER (2021)
Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket?
Robert S. O'Neill et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2021)
The role of circulating miRNAs and CA19-9 in pancreatic cancer diagnosis
Nivaldo Faria Vieira et al.
Oncotarget (2021)
Low Serum miR-607 Level as a Potential Diagnostic and Prognostic Biomarker in Patients of Pancreatic Ductal Adenocarcinoma: A Preliminary Study
Dawei Jiang et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)
Serum miRNA Profiling for Early PDAC Diagnosis and Prognosis: A Retrospective Study
Ada Aita et al.
BIOMEDICINES (2021)
Meta-analysis of the Diagnostic Performance of Circulating MicroRNAs for Pancreatic Cancer
Cheng Peng et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2021)
Diagnostic performance for declined microRNA-133a in pancreatic cancer
Zhenyong Wang
JOURNAL OF CELLULAR BIOCHEMISTRY (2020)
Circulating miRNA analysis for cancer diagnostics and therapy
Lukas Valihrach et al.
MOLECULAR ASPECTS OF MEDICINE (2020)
Plasma miR-181a-5p Downregulation Predicts Response and Improved Survival After FOLFIRINOX in Pancreatic Ductal Adenocarcinoma
Laura L. Meijer et al.
ANNALS OF SURGERY (2020)
Integrating circulating miRNA analysis in the clinical management of lung cancer: Present or future?
Rita Lampignano et al.
MOLECULAR ASPECTS OF MEDICINE (2020)
Clinical Significance of Circulating miR-1273g-3p and miR-122-5p in Pancreatic Cancer
Tommaso Mazza et al.
FRONTIERS IN ONCOLOGY (2020)
Global Burden of 5 Major Types of Gastrointestinal Cancer
Melina Arnold et al.
GASTROENTEROLOGY (2020)
Neutrophil to lymphocyte ratio, not platelet to lymphocyte or lymphocyte to monocyte ratio, is predictive of patient survival after resection of early-stage pancreatic ductal adenocarcinoma
David T. Pointer et al.
BMC CANCER (2020)
Identification and Validation of Circulating Micrornas as Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma Patients Undergoing Surgical Resection
Natalia Gablo et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Diagnostic Value of Plasma miR-181b, miR-196a, and miR-210 Combination in Pancreatic Cancer
Gongpan Liu et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2020)
Identification of Serum microRNA-25 as a novel biomarker for pancreatic cancer
Yiwen Yu et al.
MEDICINE (2020)
Early Detection of Pancreatic Cancer: Role of Biomarkers in Pancreatic Fluid Samples
Noboru Ideno et al.
DIAGNOSTICS (2020)
Serum miR-1290 and miR-1246 as Potential Diagnostic Biomarkers of Human Pancreatic Cancer
Jia Wei et al.
JOURNAL OF CANCER (2020)
miRNA-based biomarkers, therapies, and resistance in Cancer
Boxue He et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)
MiR-20a-5p regulates gemcitabine chemosensitivity by targeting RRM2 in pancreatic cancer cells and serves as a predictor for gemcitabine-based chemotherapy
Huimin Lu et al.
BIOSCIENCE REPORTS (2019)
Molecular subtypes of pancreatic cancer
Eric A. Collisson et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis
Xuan Zou et al.
CANCER MEDICINE (2019)
Novel Circulating miRNA Signatures for Early Detection of Pancreatic Neoplasia
Elena Vila-Navarro et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2019)
Circulating biomarkers for early detection and clinical management of colorectal cancer
Maria Marcuello et al.
MOLECULAR ASPECTS OF MEDICINE (2019)
MicroRNAs in Pancreatic Cancer: biomarkers, prognostic, and therapeutic modulators
Afra Z. Daoud et al.
BMC CANCER (2019)
Biosensors for early diagnosis of pancreatic cancer: a review
Lisheng Qian et al.
TRANSLATIONAL RESEARCH (2019)
Immune-Related Circulating miR-125b-5p and miR-99a-5p Reveal a High Recurrence Risk Group of Pancreatic Cancer Patients after Tumor Resection
Eveline E. Vietsch et al.
APPLIED SCIENCES-BASEL (2019)
Urinary Excretion of MicroRNA-126 Is a Biomarker for Hemangioma Proliferation
Leonidas Pavlidis et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2018)
Fibrosis-related miRNAs as serum biomarkers for pancreatic ductal adenocarcinoma
Rei Suzuki et al.
ONCOTARGET (2018)
Plasma Micro-RNA Alterations Appear Late in Pancreatic Cancer
Oskar Franklin et al.
ANNALS OF SURGERY (2018)
CircRNA circ_0026344 as a prognostic biomarker suppresses colorectal cancer progression via microRNA-21 and microRNA-31
Yuan Yuan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis
Xin Zhou et al.
GENE (2018)
Challenges in diagnosis of pancreatic cancer
Lulu Zhang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Pre-operative Plasma miR-21-5p Is a Sensitive Biomarker and Independent Prognostic Factor in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Surgical Resection
Petr Karasek et al.
CANCER GENOMICS & PROTEOMICS (2018)
Circulating microRNA-99 family as liquid biopsy marker in pancreatic adenocarcinoma
Anda J. Stroese et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
The ambiguous role of microRNA-205 and its clinical potential in pancreatic ductal adenocarcinoma
Max Michael Traeger et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
Clinical utilization of serum-or plasma-based miRNAs as early detection biomarkers for pancreatic cancer A meta-analysis up to now
Lunshou Wei et al.
MEDICINE (2018)
The Combination of MiRNA-196b, LCN2, and TIMP1 is a Potential Set of Circulating Biomarkers for Screening Individuals at Risk for Familial Pancreatic Cancer
Detlef K. Bartsch et al.
JOURNAL OF CLINICAL MEDICINE (2018)
Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes
Andrew McGuigan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Prognostic significance of circulating microRNA-21 expression in esophageal, pancreatic and colorectal cancers; a systematic review and meta-analysis
Salman Guraya
INTERNATIONAL JOURNAL OF SURGERY (2018)
A two-miRNA signature (miR-33a-5p and miR-128-3p) in whole blood as potential biomarker for early diagnosis of lung cancer
Jinchang Pan et al.
SCIENTIFIC REPORTS (2018)
Droplet digital PCR quantification of miR-1290 as a circulating biomarker for pancreatic cancer
Francesca Tavano et al.
SCIENTIFIC REPORTS (2018)
Plasma miR-22-3p, miR-642b-3p and miR-885-5p as diagnostic biomarkers for pancreatic cancer
Neveen Abd El Moneim Hussein et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2017)
Plasma microRNAs as biomarkers of pancreatic cancer risk in a prospective cohort study
Eric J. Duell et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers
Rimi Hamam et al.
CELL DEATH & DISEASE (2017)
Clinically relevant circulating microRNA profiling studies in pancreatic cancer using meta-analysis
Zenglin Pei et al.
ONCOTARGET (2017)
Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreatic cancer
Taisuke Imamura et al.
SCIENTIFIC REPORTS (2017)
Evaluation of Plasma MicroRNAs as Diagnostic and Prognostic Biomarkers in Pancreatic Adenocarcinoma: miR-196a and miR-210 Could Be Negative and Positive Prognostic Markers, Respectively
Qi Yu et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Stability of Circulating Blood-Based MicroRNAs - Pre-Analytic Methodological Considerations
Charlotte Glinge et al.
PLOS ONE (2017)
Circulating miRNA-21-5p as a diagnostic biomarker for pancreatic cancer: evidence from comprehensive miRNA expression profiling analysis and clinical validation
Kai Qu et al.
SCIENTIFIC REPORTS (2017)
Low serum miR-373 predicts poor prognosis in patients with pancreatic cancer
Yongqiang Hua et al.
CANCER BIOMARKERS (2017)
Variability in, variability out: best practice recommendations to standardize pre-analytical variables in the detection of circulating and tissue microRNAs
Jenna Khana et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2017)
More deaths from pancreatic cancer than breast cancer in the EU by 2017
J. Ferlay et al.
ACTA ONCOLOGICA (2016)
Plasma miRNAs Effectively Distinguish Patients With Pancreatic Cancer From Controls A Multicenter Study
Jianwei Xu et al.
ANNALS OF SURGERY (2016)
Identification of Circulating MiR-25 as a Potential Biomarker for Pancreatic Cancer Diagnosis
Ting Deng et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)
The potential diagnostic value of serum microRNA signature in patients with pancreatic cancer
Julia S. Johansen et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
miRNA-21 and miRNA-34a Are Potential Minimally Invasive Biomarkers for the Diagnosis of Pancreatic Ductal Adenocarcinoma
Barbara Alemar et al.
PANCREAS (2016)
Serum microRNA-196 and microRNA-200 in pancreatic ductal adenocarcinoma of patients with diabetes mellitus
Pavel Skrha et al.
PANCREATOLOGY (2016)
Epidemiology of pancreatic cancer
Milena Ilic et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
New combined microRNA and protein plasmatic biomarker panel for pancreatic cancer
Wei Yuan et al.
ONCOTARGET (2016)
Pancreatic cancer
Jorg Kleeff et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Specific MAPK-Associated MicroRNAs in Serum Differentiate Pancreatic Cancer from Autoimmune Pancreatitis
Manabu Akamatsu et al.
PLOS ONE (2016)
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upaEuro
M. Ducreux et al.
ANNALS OF ONCOLOGY (2015)
Optimized microRNA purification from TRIzol-treated plasma
Janice Duy et al.
BMC GENOMICS (2015)
Associations of circulating plasma microRNAs with age, body mass index and sex in a population-based study
Sabine Ameling et al.
BMC MEDICAL GENOMICS (2015)
Plasma microRNA profiles: identification of miR-744 as a novel diagnostic and prognostic biomarker in pancreatic cancer
Mahito Miyamae et al.
BRITISH JOURNAL OF CANCER (2015)
Malignant potential in pancreatic neoplasm; new insights provided by circulating miR-223 in plasma
Shuhei Komatsu et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2015)
miRNA Stability in Frozen Plasma Samples
Francesca Balzano et al.
MOLECULES (2015)
Salivary microRNAs Show Potential as a Noninvasive Biomarker for Detecting Resectable Pancreatic Cancer
Zijun Xie et al.
CANCER PREVENTION RESEARCH (2015)
Circulating miR-483-3p and miR-21 is highly expressed in plasma of pancreatic cancer
Makoto Abue et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Salivary MicroRNA in Pancreatic Cancer Patients
Marine Humeau et al.
PLOS ONE (2015)
A Pilot Study to Develop a Diagnostic Test for Pancreatic Ductal Adenocarcinoma Based on Differential Expression of Select miRNA in Plasma and Bile
Gregory A. Cote et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
MicroRNA Biomarkers in Whole Blood for Detection of Pancreatic Cancer
Nicolai A. Schultz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Circulating microRNA-182 in plasma and its potential diagnostic and prognostic value for pancreatic cancer
Qiulan Chen et al.
MEDICAL ONCOLOGY (2014)
microRNAs are biomarkers of oncogenic human papillomavirus infections
Xiaohong Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
MicroRNA-196a and-196b as Potential Biomarkers for the Early Detection of Familial Pancreatic Cancer
Emily P. Slater et al.
TRANSLATIONAL ONCOLOGY (2014)
Imaging diagnosis of pancreatic cancer: A state-of-the-art review
Eun Sun Lee et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Novel blood-based microRNA biomarker panel for early diagnosis of pancreatic cancer
Ganepola A. P. Ganepola et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2014)
Clinical impact of circulating miR-221 in plasma of patients with pancreatic cancer
T. Kawaguchi et al.
BRITISH JOURNAL OF CANCER (2013)
Tolerance of Droplet-Digital PCR vs Real-Time Quantitative PCR to Inhibitory Substances
Tanis C. Dingle et al.
CLINICAL CHEMISTRY (2013)
The serum miR-21 level serves as a predictor for the chemosensitivity of advanced pancreatic cancer, and miR-21 expression confers chemoresistance by targeting FasL
Peng Wang et al.
MOLECULAR ONCOLOGY (2013)
Absolute quantification by droplet digital PCR versus analog real-time PCR
Christopher M. Hindson et al.
NATURE METHODS (2013)
From Differences in Means between Cases and Controls to Risk Stratification: A Business Plan for Biomarker Development
Nicolas Wentzensen et al.
CANCER DISCOVERY (2013)
Method for microRNA isolation from clinical serum samples
Yu Li et al.
ANALYTICAL BIOCHEMISTRY (2012)
Serum MicroRNA Expression Profile as a Biomarker in the Diagnosis and Prognosis of Pancreatic Cancer
Rui Liu et al.
CLINICAL CHEMISTRY (2012)
Combination of plasma microRNAs with serum CA19-9 for early detection of pancreatic cancer
Jianqiang Liu et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies
Penny F. Whiting et al.
ANNALS OF INTERNAL MEDICINE (2011)
Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system
Alexander Baraniskin et al.
BLOOD (2011)
Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer
R. Morimura et al.
BRITISH JOURNAL OF CANCER (2011)
Detection of Differentially Expressed microRNAs in Serum of Pancreatic Ductal Adenocarcinoma Patients: miR-196a Could Be a Potential Marker for Poor Prognosis
Xiangyu Kong et al.
DIGESTIVE DISEASES AND SCIENCES (2011)
Haemolysis during Sample Preparation Alters microRNA Content of Plasma
Michaela B. Kirschner et al.
PLOS ONE (2011)
Pancreatic Cancers Epigenetically Silence SIP1 and Hypomethylate and Overexpress miR-200a/200b in Association with Elevated Circulating miR-200a and miR-200b Levels
Ang Li et al.
CANCER RESEARCH (2010)
MicroRNAs in Plasma of Pancreatic Ductal Adenocarcinoma Patients as Novel Blood-Based Biomarkers of Disease
Jin Wang et al.
CANCER PREVENTION RESEARCH (2009)
CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial
Viviane Hess et al.
LANCET ONCOLOGY (2008)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
分享论文
